Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Mu Agonist Opioids and Kappa Opioids | Download Table
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
κ-opioid receptor - Wikipedia
Kappa Receptors – Opioid Peptides
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
κ-opioid receptor - Wikipedia
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
The Kappa Opioid Receptor | SpringerLink
Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor | Journal of Medicinal Chemistry
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioids in cancer: The κ‑opioid receptor (Review)
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
